Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division (Bruker Corporation, Nasdaq: BRKR) announces ...

Trump’s prescription drugs gambit

When the Trump administration announced its Most Favored Nation policy, it was portrayed as a simple, sensible idea. Drug ...

R. Madhavan on Parenting: 5 Ways to raise kinder, more patient kids

R. Madhavan is often admired not only for his films, but also for the calm, values-driven way he talks about raising his son, ...

Biomarker-led trials to guide the future of precision psychiatry

Validated biomarkers will help physicians identify patient subgroups that will benefit most from specific treatment ...
Business Day

Our governance strength is independently validated by dual AA credit ratings from Agusto & Co. and GCR Ratings, a powerful testament to our financial soundness an…

Kai Orga, Managing Director of ARM investment Managers, in this interview with BusinessDay, breaks down the transition of ...